Instituto de Investigación Sanitaria Fundación Jiménez Díaz-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations

    Journal of Clinical Medicine, Vol. 12, Núm. 19